EU workshop

15 October 2024 – 9.00 – 12.00 CET

Martin's Brussels EU

Boulevard Charlemagne 80, Brussels 1000, Belgium

Meeting Room: Amber & Bronze

Moderator: Daniela Quaggia, Senior Project Manager, Active Citizenship Network (ACN)

9:00-9:15 Introduction:
Mariano Votta, Director, Active Citizenship Network. Read the introduction

9:15 – 10:15: Part A - Educational session (including Q&A)

The burden of vaccine-preventable respiratory diseases (VPRDs): flu, pneumococcal pneumonia, RSV on adults and at-risk populations - Stefania Maggi, Executive Committee Member and Treasurer at the European Scientific Working group on Influenza and other Respiratory Viruses (ESWI). Read the presentation

Prevention & vaccinations against VPRDs from a public health perspective - Colin Russell, Professor of Applied Evolutionary Biology, co-Chair of the Steering Group on Influenza Vaccination and Chair of ESWI. Read the presentation

10:15 – 11:15: Part B – Advocacy & communication session (including Q&A)

Sharing EU and national good practices for vaccination promotion on VPRDs:

EU Flu Day 2024 - Colin Russell, Professor of Applied Evolutionary Biology, co-Chair of the Steering Group on Influenza Vaccination and Chair of ESWI. Read the presentation

Assessing the burden of pneumococcal disease in Europe and its impact on health systems - Zachary Desson, European Health Management Association (EHMA). Read the presentation

Poland: Vaccine-preventable respiratory diseases: challenges and recommendations for the future - Marta Kulpa, Institute of Patients' Rights and Health Education. Read the presentation

11:15 – 11:45 Active citizens in Europe advocate for (adult) vaccination

Social media #VaccinAction 2024 Campaign - Stripe Health team: Joanna Muller, Sarah Carter. See the campaign

Policy recommendations “Decalogue for promoting vaccination: the citizens' perspective for the new EU institutions - Daniela Quaggia, Senior Project Manager, Active Citizenship Network Read the presentation

11.45- 12.00: Part C – Next steps

• Final remarks – ACN team

MEDIA PARTNERS 

WITH THE SUPPORT OF